Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ONVO Relative to the S&P 500

ONVO Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Organovo Holdings, Inc. (NASD:ONVO) seasonal charts above shows that a Buy Date of October 25 and a Sell Date of January 16 has resulted in a geometric average return of 4.48% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 45.16% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as?preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

To download ONVO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ONVO